Your browser doesn't support javascript.
loading
International multicenter randomized, placebo-controlled phase III clinical trial of ß-D-mannuronic acid in rheumatoid arthritis patients.
Rezaieyazdi, Zahra; Farooqi, Abid; Soleymani-Salehabadi, Hossein; Ahmadzadeh, Arman; Aslani, Mona; Omidian, Saiedeh; Sadoughi, Arezoo; Vahidi, Zohreh; Khodashahi, Mandana; Zamurrad, Shazia; Mortazavi-Jahromi, Seyed Shahabeddin; Fallahzadeh, Hossein; Hosseini, Mostafa; Aghazadeh, Zahra; Ekhtiari, Parvin; Matsuo, Hidenori; Rehm, Bernd H A; Cuzzocrea, Salvatore; D'Aniello, Antimo; Mirshafiey, Abbas.
Affiliation
  • Rezaieyazdi Z; Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Farooqi A; Department of Rheumatology, Pakistan Institute of Medical Sciences, Islamabad, Pakistan.
  • Soleymani-Salehabadi H; Department of Rheumatology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Ahmadzadeh A; Department of Rheumatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Aslani M; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Box: 14155-6446, Tehran, Iran.
  • Omidian S; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Box: 14155-6446, Tehran, Iran.
  • Sadoughi A; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Box: 14155-6446, Tehran, Iran.
  • Vahidi Z; Inflammation and Inflammatory Diseases Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Khodashahi M; Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Zamurrad S; Department of Rheumatology, Pakistan Institute of Medical Sciences, Islamabad, Pakistan.
  • Mortazavi-Jahromi SS; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Box: 14155-6446, Tehran, Iran.
  • Fallahzadeh H; Research Center of Prevention and Epidemiology of Non-Communicable Disease, Departments of Biostatistics and Epidemiology, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Hosseini M; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Aghazadeh Z; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Box: 14155-6446, Tehran, Iran.
  • Ekhtiari P; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Box: 14155-6446, Tehran, Iran.
  • Matsuo H; Nagasaki National Hospital, Sakuragi-cho 6-41, Nagasaki, Japan.
  • Rehm BHA; Centre for Cell Factories and Biopolymers, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
  • Cuzzocrea S; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.
  • D'Aniello A; Laboratory of Neurobiology, Zoological Station of Naples "Anton Dohrn", Villa Comunale, Naples, Italy.
  • Mirshafiey A; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Box: 14155-6446, Tehran, Iran. mirshafiey@tums.ac.ir.
Inflammopharmacology ; 27(5): 911-921, 2019 Oct.
Article in En | MEDLINE | ID: mdl-30604197

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Hexuronic Acids Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Inflammopharmacology Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Type: Article Affiliation country: Iran

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Hexuronic Acids Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Inflammopharmacology Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Type: Article Affiliation country: Iran